Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Raw Materials: 2024

Historic Raw Materials for Whitehawk Therapeutics (WHWK) over the last 1 years, with Dec 2024 value amounting to $3.5 million.

  • Whitehawk Therapeutics' Raw Materials was N/A to $3.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $3.5 million, marking a year-over-year change of. This contributed to the annual value of $3.5 million for FY2024, which is N/A change from last year.
  • As of FY2024, Whitehawk Therapeutics' Raw Materials stood at $3.5 million.
  • In the past 5 years, Whitehawk Therapeutics' Raw Materials registered a high of $3.5 million during FY2024, and its lowest value of $3.5 million during FY2024.
  • Its 1-year average for Raw Materials is $3.5 million, with a median of $3.5 million in 2024.